[STUDY OF SIDEREMIA IN SUBJECTS WITH PROGRESSIVE MUSCULAR DYSTROPHY IN BASIC CONDITIONS AND AFTER RE-METABOLIZING THERAPY].
D000293:Adolescent; D000690:Amyotrophic Lateral Sclerosis; D045930:Anabolic Agents; D001774:Blood Chemical Analysis; D002648:Child; D006801:Humans; D007501:Iron / Q000378:metabolism*; D008274:Magnesium; D008715:Methionine; D009133:Muscular Atrophy; D009135:Muscular Diseases; D009136:Muscular Dystrophies; D009220:Myositis; D009223:Myotonic Dystrophy; D009336:Necrosis; D010600:Pharmacology; D011051:Poliomyelitis; D011188:Potassium; D013256:Steroids; D014500:Uracil Nucleotides; D014810:Vitamin E
D045930:Anabolic Agents; D013256:Steroids; D014500:Uracil Nucleotides; D014810:Vitamin E; D008715:Methionine; D007501:Iron; D008274:Magnesium; D011188:Potassium
ADOLESCENCE; AMYOTROPHIC LATERAL SCLEROSIS; ANABOLIC STEROIDS; BLOOD CHEMICAL ANALYSIS; CHILD; IRON; IRON METABOLISM; MAGNESIUM; METHIONINE; MUSCULAR ATROPHY; MUSCULAR DISEASES; MUSCULAR DYSTROPHY; MYOSITIS; MYOTONIA ATROPHICA; NECROSIS; PHARMACOLOGY; POLIOMYELITIS; POTASSIUM; URACIL NUCLEOTIDES; VITAMIN E
STUDIO SULLA SIDEREMIA DI SOGGETTI CON DISTROFIA MUSCOLARE PROGRESSIVA IN CONDIZIONI BASALI E DOPO TERAPIA RIMETABOLIZZANTE.